NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Debt-to-equity for the quarter ending September 30, 2024 was 77.6 %, a 171% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 77.6 +48.9 +171% Sep 30, 2024
Q2 2024 38.2 +8 +26.5% Jun 30, 2024
Q1 2024 35.9 +14.3 +66.4% Mar 31, 2024
Q4 2023 33.6 +17.6 +111% Dec 31, 2023
Q3 2023 28.7 +15.7 +122% Sep 30, 2023
Q2 2023 30.2 +20.4 +207% Jun 30, 2023
Q1 2023 21.6 +11.4 +112% Mar 31, 2023
Q4 2022 16 +4.99 +45.5% Dec 31, 2022
Q3 2022 12.9 -22.8 -63.9% Sep 30, 2022
Q2 2022 9.82 -38.5 -79.7% Jun 30, 2022
Q1 2022 10.2 -169 -94.3% Mar 31, 2022
Q4 2021 11 +440 Dec 31, 2021
Q3 2021 35.8 +250 Sep 30, 2021
Q2 2021 48.3 +209 Jun 30, 2021
Q1 2021 179 +333 Mar 31, 2021
Q4 2020 -429 -200 -87.5% Dec 31, 2020
Q3 2020 -214 -27.2 -14.6% Sep 30, 2020
Q2 2020 -160 -7 -4.56% Jun 30, 2020
Q1 2020 -154 -31.9 -26.1% Mar 31, 2020
Q4 2019 -229 -123 -117% Dec 31, 2019
Q3 2019 -187 -82.6 -79.4% Sep 30, 2019
Q2 2019 -153 -49 -46.9% Jun 30, 2019
Q1 2019 -122 -17.2 -16.4% Mar 31, 2019
Q4 2018 -106 +0.37 +0.35% Dec 31, 2018
Q3 2018 -104 +21.4 +17% Sep 30, 2018
Q2 2018 -104 +121 +53.8% Jun 30, 2018
Q1 2018 -105 +128 +54.9% Mar 31, 2018
Q4 2017 -106 +132 +55.5% Dec 31, 2017
Q3 2017 -125 -22.2 -21.4% Sep 30, 2017
Q2 2017 -226 -123 -120% Jun 30, 2017
Q1 2017 -233 -131 -130% Mar 31, 2017
Q4 2016 -238 -137 -135% Dec 31, 2016
Q3 2016 -103 -2.78 -2.77% Sep 30, 2016
Q2 2016 -102 -1.57 -1.56% Jun 30, 2016
Q1 2016 -101 -0.01 -0.01% Mar 31, 2016
Q4 2015 -101 +1.27 +1.24% Dec 31, 2015
Q3 2015 -101 +2.42 +2.35% Sep 30, 2015
Q2 2015 -101 +1.95 +1.9% Jun 30, 2015
Q1 2015 -101 +1.93 +1.87% Mar 31, 2015
Q4 2014 -102 +5.1 +4.75% Dec 31, 2014
Q3 2014 -103 +6.3 +5.77% Sep 30, 2014
Q2 2014 -103 +9.06 +8.1% Jun 30, 2014
Q1 2014 -103 +18.9 +15.5% Mar 31, 2014
Q4 2013 -107 +24.5 +18.6% Dec 31, 2013
Q3 2013 -109 +66.7 +37.9% Sep 30, 2013
Q2 2013 -112 +81.5 +42.1% Jun 30, 2013
Q1 2013 -122 +44.4 +26.6% Mar 31, 2013
Q4 2012 -132 Dec 31, 2012
Q3 2012 -176 Sep 30, 2012
Q2 2012 -193 Jun 30, 2012
Q1 2012 -167 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.